These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


89 related items for PubMed ID: 9443342

  • 21. Inhibitor binding to the plasmepsin IV aspartic protease from Plasmodium falciparum.
    Gutiérrez-de-Terán H, Nervall M, Ersmark K, Liu P, Janka LK, Dunn B, Hallberg A, Aqvist J.
    Biochemistry; 2006 Sep 05; 45(35):10529-41. PubMed ID: 16939205
    [Abstract] [Full Text] [Related]

  • 22. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH, Schiewe AJ, von Grafenstein H, Haworth IS.
    Proteins; 2006 Apr 01; 63(1):43-52. PubMed ID: 16447245
    [Abstract] [Full Text] [Related]

  • 23. Replacement of isobutyl by trifluoromethyl in pepstatin A selectively affects inhibition of aspartic proteinases.
    Binkert C, Frigerio M, Jones A, Meyer S, Pesenti C, Prade L, Viani F, Zanda M.
    Chembiochem; 2006 Jan 01; 7(1):181-6. PubMed ID: 16307463
    [Abstract] [Full Text] [Related]

  • 24. Structure-based subsite specificity mapping of human cathepsin D using statine-based inhibitors.
    Majer P, Collins JR, Gulnik SV, Erickson JW.
    Protein Sci; 1997 Jul 01; 6(7):1458-66. PubMed ID: 9232647
    [Abstract] [Full Text] [Related]

  • 25. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA, Lu SM, Ding J, Bateman KS, James MN, Anderson S, Song J, Markley JL, Ganz PJ, Saunders CW, Laskowski M.
    Biochemistry; 1999 Jun 01; 38(22):7142-50. PubMed ID: 10353824
    [Abstract] [Full Text] [Related]

  • 26. Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors.
    Ferrari AM, Degliesposti G, Sgobba M, Rastelli G.
    Bioorg Med Chem; 2007 Dec 15; 15(24):7865-77. PubMed ID: 17870536
    [Abstract] [Full Text] [Related]

  • 27. Computational analysis of plasmepsin IV bound to an allophenylnorstatine inhibitor.
    Gutiérrez-de-Terán H, Nervall M, Dunn BM, Clemente JC, Aqvist J.
    FEBS Lett; 2006 Oct 30; 580(25):5910-6. PubMed ID: 17045991
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Empirical free energy calculations: a blind test and further improvements to the method.
    Novotny J, Bruccoleri RE, Davis M, Sharp KA.
    J Mol Biol; 1997 May 02; 268(2):401-11. PubMed ID: 9159479
    [Abstract] [Full Text] [Related]

  • 30. Combination of a modified scoring function with two-dimensional descriptors for calculation of binding affinities of bulky, flexible ligands to proteins.
    Hetényi C, Paragi G, Maran U, Timár Z, Karelson M, Penke B.
    J Am Chem Soc; 2006 Feb 01; 128(4):1233-9. PubMed ID: 16433540
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. New parameterization approaches of the LIE method to improve free energy calculations of PlmII-Inhibitors complexes.
    Valiente PA, Gil A, Batista PR, Caffarena ER, Pons T, Pascutti PG.
    J Comput Chem; 2010 Nov 30; 31(15):2723-34. PubMed ID: 20839299
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin.
    Fujimoto Z, Fujii Y, Kaneko S, Kobayashi H, Mizuno H.
    J Mol Biol; 2004 Aug 27; 341(5):1227-35. PubMed ID: 15321718
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The binding energetics of first- and second-generation HIV-1 protease inhibitors: implications for drug design.
    Velazquez-Campoy A, Kiso Y, Freire E.
    Arch Biochem Biophys; 2001 Jun 15; 390(2):169-75. PubMed ID: 11396919
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.